POSTECH researchers found Alzheimer's tau protein disrupts chromosome segregation during cell division, opening a new class of therapeutic targets.
Technology Networks and SciTechDaily cover the POSTECH finding; the research links tau's dual role to chromosomal instability.
Science Twitter is calling this a paradigm shift — tau was never supposed to be a cell division protein, which makes the finding stranger and more significant.
Tau is one of those proteins you learn about in the context of what it does wrong. In Alzheimer's disease, tau misfolds, forms tangles, and kills neurons. That has been the story for four decades. Researchers at POSTECH in South Korea have now found that the story has a second chapter — and it begins in the cell's most fundamental activity. [1]
The POSTECH team discovered that tau plays a crucial role in cell division: specifically, in ensuring that chromosomes separate correctly during mitosis. In healthy cells, tau helps coordinate the microtubule network that pulls chromosomes to opposite poles before the cell splits. [1] This was not expected. Tau was understood as a protein that stabilized microtubules in neurons — its involvement in the actual mechanics of division changes the picture.
The pathological implication follows directly. When tau acquires the disease-like modifications seen in Alzheimer's patients — the hyperphosphorylation that precedes tangle formation — chromosomes fail to align properly during division. [2] They segregate incorrectly. The result is chromosomal instability, a state that has long been observed in Alzheimer's brain tissue but never fully explained. [1]
The mechanism the POSTECH team proposes is a tau-DNA condensate: tau forms a kind of molecular scaffold that links chromosomes to the microtubule apparatus. When disease-modified tau disrupts this scaffold, the fidelity of division collapses. [1]
What makes this finding clinically interesting is not just the mechanism but the timing. Chromosomal instability appears early in the Alzheimer's disease progression — before significant neuronal death has occurred. [2] If tau's role in cell division is part of why that instability develops, it suggests a window for intervention that the field has not previously considered. Therapeutic targets focused on tau's role in division, rather than just its aggregation, could reach the disease at an earlier stage.
The research does not immediately suggest a treatment. It suggests a place to look for one that the field has been missing. In a disease where every clinical trial aimed at clearing amyloid plaques has struggled, a new mechanism is precisely what the next generation of researchers needs. [2]
-- KENJI NAKAMURA, Tokyo